Stay updated on Pediatric Hodgkin's Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pediatric Hodgkin's Lymphoma Clinical Trial page.

Latest updates to the Pediatric Hodgkin's Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for CheckMate 744 is now available, describing the nivolumab and brentuximab vedotin study for young people with relapsed or refractory Hodgkin lymphoma. It includes eligibility criteria, study outcomes and results, locations, completion status, publications, and study documents.SummaryDifference100%

- Check12 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site revision number in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision: v3.7.0 has been introduced, and numerous sponsor- and document-related sections were removed from the Study Details page. This change narrows the displayed information about the trial and alters how users access core study details.SummaryDifference20%

Stay in the know with updates to Pediatric Hodgkin's Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Hodgkin's Lymphoma Clinical Trial page.